BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15094046)

  • 1. Generation of SUMO-1 modified proteins in E. coli: towards understanding the biochemistry/structural biology of the SUMO-1 pathway.
    Uchimura Y; Nakao M; Saitoh H
    FEBS Lett; 2004 Apr; 564(1-2):85-90. PubMed ID: 15094046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of the Recombinant RanBP2 SUMO E3 Ligase Complex.
    Ritterhoff T; Das H; Hao Y; Sakin V; Flotho A; Werner A; Melchior F
    Methods Mol Biol; 2016; 1475():41-54. PubMed ID: 27631796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and Purification of Recombinant SUMOylated Proteins Using Engineered Bacteria.
    Brockly F; Piechaczyk M; Bossis G
    Methods Mol Biol; 2016; 1475():55-65. PubMed ID: 27631797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Characterization of SUMO-SIM Interactions.
    Husnjak K; Keiten-Schmitz J; Müller S
    Methods Mol Biol; 2016; 1475():79-98. PubMed ID: 27631799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins.
    Song J; Durrin LK; Wilkinson TA; Krontiris TG; Chen Y
    Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14373-8. PubMed ID: 15388847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Versatile recombinant SUMOylation system for the production of SUMO-modified protein.
    Weber AR; Schuermann D; Schär P
    PLoS One; 2014; 9(7):e102157. PubMed ID: 25007328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-Time Surface Plasmon Resonance (SPR) for the Analysis of Interactions Between SUMO Traps and Mono- or PolySUMO Moieties.
    Xolalpa W; Rodriguez MS; England P
    Methods Mol Biol; 2016; 1475():99-107. PubMed ID: 27631800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotin-ubiquitin tagging of mammalian proteins in Escherichia coli.
    Wang T; Evdokimov E; Yiadom K; Yan Z; Chock PB; Yang DC
    Protein Expr Purif; 2003 Jul; 30(1):140-9. PubMed ID: 12821332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex.
    Matunis MJ; Wu J; Blobel G
    J Cell Biol; 1998 Feb; 140(3):499-509. PubMed ID: 9456312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of SUMO-1 modified IκBα and complex formation with NF-κB.
    Lens Z; Dewitte F; Van Lint C; de Launoit Y; Villeret V; Verger A
    Protein Expr Purif; 2011 Dec; 80(2):211-6. PubMed ID: 21708266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and dynamic independence of isopeptide-linked RanGAP1 and SUMO-1.
    Macauley MS; Errington WJ; Okon M; Schärpf M; Mackereth CD; Schulman BA; McIntosh LP
    J Biol Chem; 2004 Nov; 279(47):49131-7. PubMed ID: 15355965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SUMO-1 targets RanGAP1 to kinetochores and mitotic spindles.
    Joseph J; Tan SH; Karpova TS; McNally JG; Dasso M
    J Cell Biol; 2002 Feb; 156(4):595-602. PubMed ID: 11854305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for the expression of SUMO-modified target proteins in Escherichia coli.
    Saitoh H; Uwada J; Azusa K
    Methods Mol Biol; 2009; 497():211-21. PubMed ID: 19107420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMO modification through rapamycin-mediated heterodimerization reveals a dual role for Ubc9 in targeting RanGAP1 to nuclear pore complexes.
    Zhu S; Zhang H; Matunis MJ
    Exp Cell Res; 2006 Apr; 312(7):1042-9. PubMed ID: 16469311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
    Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Fluorescent In Vitro Assay to Investigate Paralog-Specific SUMO Conjugation.
    Eisenhardt N; Chaugule VK; Pichler A
    Methods Mol Biol; 2016; 1475():67-78. PubMed ID: 27631798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.
    Reverter D; Lima CD
    Nature; 2005 Jun; 435(7042):687-92. PubMed ID: 15931224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2.
    Okuma T; Honda R; Ichikawa G; Tsumagari N; Yasuda H
    Biochem Biophys Res Commun; 1999 Jan; 254(3):693-8. PubMed ID: 9920803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chip-based analysis of SUMO (small ubiquitin-like modifier) conjugation to a target protein.
    Oh YH; Hong MY; Jin Z; Lee T; Han MK; Park S; Kim HS
    Biosens Bioelectron; 2007 Feb; 22(7):1260-7. PubMed ID: 16820290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of in vitro SUMOylation using bioluminescence resonance energy transfer (BRET).
    Kim YP; Jin Z; Kim E; Park S; Oh YH; Kim HS
    Biochem Biophys Res Commun; 2009 May; 382(3):530-4. PubMed ID: 19289109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.